Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people...

Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people...

Neonatology

Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the...

Neonatology

Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the...

Rare Diseases

Rare Diseases The term rare applies to those diseases affecting a limited number of people with...

Rare Diseases

Rare Diseases The term rare applies to those diseases affecting a limited number of people with...

02
08/19

NEWS

Chiesi Group Announces Closing of Licensing Transaction with Santhera for an...

Chiesi Farmaceutici, an international research-focused healthcare group (Chiesi Group), announces the closing...

PRESS RELEASE

SINGLE-INHALER EXTRAFINE TRIPLE THERAPY OF INHALED CORTICOSTEROID PLUS...

Data from two randomised, double-blind, parallel-group, active-controlled studies on the efficacy and safety of single-inhaler...

Global Corporate Development

© 2019 CHIESI Farmaceutici S.p.A.

Vat 01513360345
Payed Up Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271

CHIESI ON THE WEB

follow us on: